Resistance Oncology ApS: Financial statements 2021
CVR: 36945125
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Resistance Oncology ApS (CVR 36945125) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -10,140 and a net result of DKK -8,615 compared with DKK -7,652 the year before. Equity in the 2021 report amounted to DKK -31,179.
- Gross Profit
- DKK -10,140
- Profit/Loss
- DKK -8,615
- Equity
- DKK -31,179
- Total Assets
- DKK 6,104
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -10K | -9K | -31K | - |
| 2020 | - | -10K | -8K | -23K | - |
| 2019 | - | 14K | 10K | -15K | - |
| 2018 | - | -15K | -13K | -25K | - |
| 2017 | - | 51K | 1.1M | -12K | 0 |
Official annual report
Find more companies like Resistance Oncology ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Resistance Oncology ApS has published its annual report for 2020. Gross profit came to DKK -9,500, and the net result was DKK -7,652.
About Resistance Oncology ApS
Resistance Oncology ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named 3B-Oncology ApS and Cortris Nordic ApS. The management consists of Kasper Pasternak Jørgensen and Nils Aage Brünner. The company is owned by TIMPCO-RO ApS, Alexander Meier Holding ApS and Pasternak Holding ApS. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -410,610 and a net result of DKK -665,070 compared with DKK -29,048 the year before. Equity in the 2025 report amounted to DKK 325,631.